• Return to search results
• Start new search

Investigator(s):
Howard A. Fine, M.D. Principal Investigator Phone: 301-402-6298 hfine@mail.nih.gov
Referral Contact(s):
Charisse Garcia, R.N. Research Nurse Phone: 301-402-6298 Fax: 301-480-2246 Toll free: 866-251-9686 garciacr@mail.nih.gov	Julie Peretti, R.N. Research Nurse Phone: 301-402-6298 Fax: 301-480-2246 Toll free: 866-251-9686 jperetti@mail.nih.gov	Tracy Cropper, R.N. Research Nurse Phone: 301-496-8250 Fax: 301-480-2246 Toll free: 866-251-9686 tcropper@mail.nih.gov

---

Primary Eligibility:

• Patients with radiographic suggestion of a primary glial neoplasm or known glial neoplasm
• Patients with plans to undergo a medically indicated (diagnostic and/or therapeutic) tumor resection or biopsy

---

Study Outline:

• Samples of tumor tissue will be removed as part of normal care and 10 mL of blood will be taken for genetic analysis
• Patients will be evaluated every 6 months with a physical/neurological examination and with either an MRI (preferably) or a CT scan

---

Additional Information:

• This trial will be conducted at the NIH Clinical Center in Bethesda, MD. It is open to patients who meet the eligibility requirements, regardless of where they live in the United States.
• There is no charge for medical care received at NIH Clinical Center.
• FAQs about this study - provides information for patients about the trial such as frequency and duration of visits, costs, how to enroll, treatment plan.

Reviewed: 3/5/09
Updated: 8/29/08